?:authorAffiliation
|
-
[\'Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem B-2650, Belgium; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk B-2610, Belgium. Electronic address: peter.vandam@uza.be.\', \'Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem B-2650, Belgium; Biobank, Antwerp University Hospital, Wilrijkstraat 10, Edegem B-2650, Belgium.\', \'Antwerp University, Universiteitsplein 1, Wilrijk B-2610, Belgium.\', \'Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem B-2650, Belgium; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk B-2610, Belgium.\', \'Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk B-2610, Belgium; Department of Medical Oncology, AZ Middelares Gent, Belgium.\', \'Department of Hematology, Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium.\', \'VIB-UGent Center for Medical Biotechnology, Technologiepark, Zwijnaarde 71, B-9052 Gent, Belgium.\', \'Department Biomedical Sciences, University Antwerp, PPES lab Proteinchemistry, Proteomics & Epigenetic Signaling, IPPON, Universiteitsplein 1, Wilrijk B-2610, Belgium.\', \'Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk B-2610, Belgium.\']
|